What is the ticker symbol for Cardiff Oncology?

Cardiff Oncology trades under the ticker CRDF on NASDAQ.

What sector does Cardiff Oncology operate in?

Cardiff Oncology is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CRDF in a portfolio?

PortView shows CRDF's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Cardiff Oncology (CRDF) Stock Analysis

NASDAQHealthcareBiotechnology

$1.03-0.49%

1-year price historyRange $0.81 – $3.21

52-week range$1.03

$0.76$3.31

What Cardiff Oncology does

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers in the United States. Its lead drug candidate is Onvansertib, an oral and selective polo-like kinase 1 inhibitor for treating RAS-mutated metastatic colorectal cancer. The company also focuses on the clinical program in indications, such as investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma, small cell lung cancer, metastatic triple negative breast cancer, and chronic myelomonocytic leukemia; CRDF-004, a Phase 2 open-label randomized multi-center clinical trial of onvansertib in combination with FOLFIRI and bevacizumab or FOLFOX and bevacizumab for the treatment of patients confirmed metastatic and unresectable colorectal cancer in patients with a KRAS or NRAS mutation; and TROV-054, a Phase 1b/2 single-arm clinical trial in KRAS-mutated metastatic colorectal cancer. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.

Key metrics

Market cap

$79.00M

P/E (TTM)

-1.71

EPS (TTM)

$-0.60

Beta

1.44

Dividend yield

0.00%

Revenue / share

$0.01

50-day avg

$1.03

200-day avg

$1.73

52-week high

$3.31

52-week low

$0.76

CEO

Mani Mohindru

ETFs linked to CRDF

Broad-market and Healthcare sector ETFs an investor holding Cardiff Oncology is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CRDF fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CRDF in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Cardiff Oncology?: Cardiff Oncology trades under the ticker CRDF on NASDAQ.
Which exchange is CRDF listed on?: CRDF is listed on NASDAQ.
What sector does Cardiff Oncology operate in?: Cardiff Oncology is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CRDF in a portfolio?: PortView shows CRDF's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.